Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers have used unsupervised machine learning to predict disease-causing properties in more than 36 million genetic variants across more than 3,200 disease-related genes.
New research shows horizontal gene transfer is predictable in bacteria by machine learning, a development that could lead to better weapons in the war against E. coli and other bacterial assailants that collaborate to conquer pharmacologic first responders.
Could AI help produce a unifying concept of human disease—one that might help prevent, mitigate or cure everything from birth defects and rare cancers to immune disorders and neurological defects?
The AI development team was guided by a sports-medicine specialist dubbed “the go-to orthopedic surgeon for many of the greatest athletes on the planet.”
More than one-quarter of the U.S. adult population has Gastroesophageal Reflux Disease, or GERD, and the condition saddles as many as 20% of its sufferers with Barrett’s esophagus. The latter is a serious risk factor for esophageal cancer.
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.